Guidelines (7)
Drug Sections (1)

Skin in the News

New treatments for BRAF V600 positive melanoma

Trametinib (Mekinist) and cobimetinib (Cotellic) are new targeted treatments for patients with unresectable or metastatic melanoma who have a BRAF V600 mutation

Treating lentigo maligna with imiquimod

Treating lentigo maligna with imiquimod

The gold standard of treatment for lentigo maligna is surgery, but this can result in significant scarring

New class of immunotherapy for patients with melanoma

New class of immunotherapy for patients with melanoma

Patients with advanced melanoma can now benefit from a new class of drugs targeting the immune system, with the launch of nivolumab (Opdivo) and pembrolizumab (Keytruda)

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS bulletins

News and updates straight to your inbox.

Prescribing Update: Fortnightly news bulletin
Urgent prescribing updates
Spotlight: Disease-themed monthly round-up

Sign me up

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

MIMS Adviser

Especially created for prescribing influencers.

Request free copy

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases